ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Aequus Pharmaceuticals, Inc. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-20.97%
EBIT Growth (5y)
0.85%
EBIT to Interest (avg)
-1.87
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.96
Sales to Capital Employed (avg)
0.09
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.11
EV to EBIT
-2.72
EV to EBITDA
-2.88
EV to Capital Employed
-6.64
EV to Sales
6.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bullish
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend25What is working for the Company
NET SALES(HY)
At CAD 0.45 MM has Grown at 333.61%
OPERATING CASH FLOW(Y)
Highest at CAD -1.11 MM
RAW MATERIAL COST(Y)
Fallen by -1,629.84% (YoY
INVENTORY TURNOVER RATIO(HY)
Highest at 3.9%
DEBTORS TURNOVER RATIO(HY)
Highest at 11.76%
OPERATING PROFIT(Q)
Highest at CAD -0.05 MM
PRE-TAX PROFIT(Q)
Highest at CAD -0.16 MM
NET PROFIT(Q)
Highest at CAD -0.16 MM
-10What is not working for the Company
INTEREST(HY)
At CAD 0.14 MM has Grown at 42%
DEBT-EQUITY RATIO
(HY)
Highest at -92.02 %
Here's what is working for Aequus Pharmaceuticals, Inc.
Net Sales
At CAD 0.45 MM has Grown at 333.61%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (CAD MM)
Operating Cash Flow
Highest at CAD -1.11 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CAD MM)
Operating Profit
Highest at CAD -0.05 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CAD MM)
Pre-Tax Profit
Highest at CAD -0.16 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CAD MM)
Pre-Tax Profit
At CAD -0.16 MM has Grown at 75.85%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CAD MM)
Net Profit
Highest at CAD -0.16 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CAD MM)
Net Profit
At CAD -0.16 MM has Grown at 75.85%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CAD MM)
Inventory Turnover Ratio
Highest at 3.9%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Debtors Turnover Ratio
Highest at 11.76%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -1,629.84% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Aequus Pharmaceuticals, Inc.
Interest
At CAD 0.14 MM has Grown at 42%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CAD MM)
Debt-Equity Ratio
Highest at -92.02 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
